Komoto Daisuke, Nishiyama Yoshihiro, Yamamoto Yuka, Monden Toshihide, Sasakawa Yasuhiro, Toyama Yoshihiro, Satoh Katashi, Ohno Masayuki, Kanenishi Kenji, Ohkawa Motoomi
Department of Radiology, Faculty of Medicine, Kagawa University, Kita-gun, Japan.
Ann Nucl Med. 2006 Feb;20(2):157-60. doi: 10.1007/BF02985629.
Primary ovarian lymphoma as the initial manifestation is rare. A 27-year-old woman presented to our hospital with the symptoms of lower abdominal fullness and pollakisuria. CT scan and MRI revealed bilateral ovarian tumors, which showed heterogeneous masses. 18F-FDG PET revealed strong uptake by the abdominal masses, and the maximum standardized uptake value (SUVmax) was 12.5. Abnormal uptake was not shown by other regions. An exploratory laparotomy was performed. Histological findings revealed diffuse large B-cell lymphoma. The clinical stage was IV according to the Ann Arbor system. International prognostic index (IPI) was 3 (high-intermediate risk). Chemotherapy was administered consisting of three courses of an R-CHOP regimen, and 18F-FDG PET and CT scan revealed no signs of involvement 3 months after initiation of the chemotherapy. 18F-FDG PET was a useful method for staging and assessment of the therapeutic response in primary ovarian lymphoma.
以原发性卵巢淋巴瘤为首发表现较为罕见。一名27岁女性因下腹部胀满和尿频症状前来我院就诊。CT扫描和MRI显示双侧卵巢肿瘤,表现为不均匀肿块。18F-FDG PET显示腹部肿块有强烈摄取,最大标准化摄取值(SUVmax)为12.5。其他区域未显示异常摄取。进行了剖腹探查术。组织学检查结果显示为弥漫性大B细胞淋巴瘤。根据Ann Arbor分期系统,临床分期为IV期。国际预后指数(IPI)为3(高中危)。给予三个疗程的R-CHOP方案化疗,化疗开始3个月后,18F-FDG PET和CT扫描显示无受累迹象。18F-FDG PET是原发性卵巢淋巴瘤分期和评估治疗反应的有用方法。